Literature DB >> 12084524

Neuropeptide Y Y1 and neuropeptide Y Y2 receptors in human cardiovascular tissues.

Rolf Uddman1, Sebastian Möller, Torun Nilsson, Susanne Nyström, Jonas Ekstrand, Lars Edvinsson.   

Abstract

mRNA encoding the human NPY Y1 and NPY Y2 receptors were detected in cerebral, meningeal, and coronary arteries using reverse transcriptase-polymerase chain reaction (RT-PCR). In addition, the trigeminal and superior cervical ganglia were positive for both receptors. In some arteries and in SK-N-MC cells only mRNA encoding the NPY Y1 was detected. Besides the expected NPY Y1 PCR products, an additional 97 bp longer amplicon originating from an alternative splicing event was found in most tissues studied. Antibodies directed against the NPY Y1 receptor revealed immunostaining mainly in the smooth muscle layer of blood vessels whereas antibodies against the NPY Y2 receptor showed immunostaining in nerve cell bodies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12084524     DOI: 10.1016/s0196-9781(02)00003-7

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  11 in total

Review 1.  Neuropeptide Y Y2 receptor in health and disease.

Authors:  S L Parker; A Balasubramaniam
Journal:  Br J Pharmacol       Date:  2007-09-10       Impact factor: 8.739

2.  Neuropeptide Y2 receptors are involved in enhanced neurogenic vasoconstriction in spontaneously hypertensive rats.

Authors:  Kathryn A Gradin; Carsten L Buus; Jia-Yi Li; Ole Frøbert; Ulf Simonsen
Journal:  Br J Pharmacol       Date:  2006-05-22       Impact factor: 8.739

3.  Chronic type II diabetes mellitus leads to changes in neuropeptide Y receptor expression and distribution in human myocardial tissue.

Authors:  Robina Matyal; Feroze Mahmood; Michael Robich; Hiliary Glazer; Kamal Khabbaz; Philip Hess; Cesario Bianchi; Robert Hagberg; Shu-Xu Hu; Frank W Sellke
Journal:  Eur J Pharmacol       Date:  2011-04-28       Impact factor: 4.432

Review 4.  Pathophysiology of Migraine: A Disorder of Sensory Processing.

Authors:  Peter J Goadsby; Philip R Holland; Margarida Martins-Oliveira; Jan Hoffmann; Christoph Schankin; Simon Akerman
Journal:  Physiol Rev       Date:  2017-04       Impact factor: 37.312

5.  The ability of neuropeptide Y to mediate responses in the murine cutaneous microvasculature: an analysis of the contribution of Y1 and Y2 receptors.

Authors:  Duc Quyen Chu; Helen M Cox; Soraia K P Costa; Herbert Herzog; Susan D Brain
Journal:  Br J Pharmacol       Date:  2003-08-26       Impact factor: 8.739

6.  Neuropeptide Y and its Y2 receptor: potential targets in neuroblastoma therapy.

Authors:  C Lu; L Everhart; J Tilan; L Kuo; C-C J Sun; R B Munivenkatappa; A-C Jönsson-Rylander; J Sun; A Kuan-Celarier; L Li; K Abe; Z Zukowska; J A Toretsky; J Kitlinska
Journal:  Oncogene       Date:  2010-08-02       Impact factor: 9.867

Review 7.  Neuropeptide Y and neurovascular control in skeletal muscle and skin.

Authors:  Gary J Hodges; Dwayne N Jackson; Louis Mattar; John M Johnson; J Kevin Shoemaker
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-07-01       Impact factor: 3.619

8.  Neuropeptide Y2 receptor (NPY2R) expression in saliva predicts feeding immaturity in the premature neonate.

Authors:  Jill L Maron; Kirby L Johnson; Jessica A Dietz; Minghua L Chen; Diana W Bianchi
Journal:  PLoS One       Date:  2012-05-21       Impact factor: 3.240

9.  Sympathetic innervation of human muscle spindles.

Authors:  Dina Radovanovic; Kevin Peikert; Mona Lindström; Fatima Pedrosa Domellöf
Journal:  J Anat       Date:  2015-06       Impact factor: 2.610

10.  Neuropeptide Y inhibits the trigeminovascular pathway through NPY Y1 receptor: implications for migraine.

Authors:  Margarida-Martins Oliveira; Simon Akerman; Isaura Tavares; Peter J Goadsby
Journal:  Pain       Date:  2016-08       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.